UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.12B |
| 2 |
Apple
AAPL
|
+$1.08B |
| 3 |
Microsoft
MSFT
|
+$1.05B |
| 4 |
Nike
NKE
|
+$1.03B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$821M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BioMarin Pharmaceuticals
BMRN
|
+$389M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$383M |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$348M |
| 4 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$263M |
| 5 |
NRG Energy
NRG
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.8% |
| 2 | Financials | 8.25% |
| 3 | Healthcare | 6.4% |
| 4 | Consumer Discretionary | 5.85% |
| 5 | Communication Services | 4.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5501
-1x Short VIX Futures ETF
SVIX
$185M
| $250K | ﹤0.01% |
5,239
+151
| +3% | +$6.52K |
|
|
PTVE
5502
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
| $249K | ﹤0.01% |
22,024
-26,339
| -54% | -$350K |
|
5503
Perdoceo Education
PRDO
$2.12B
| $249K | ﹤0.01% |
11,635
-31,649
| -73% | -$656K |
|
5504
Montauk Renewables
MNTK
$255M
| $249K | ﹤0.01% |
43,683
-46,860
| -52% | -$217K |
|
5505
ORIX
IX
$43.5B
| $249K | ﹤0.01% |
11,175
-4,570
| -29% | -$97.6K |
|
5506
Ooma
OOMA
$604M
| $248K | ﹤0.01% |
24,999
-7,488
| -23% | -$59.5K |
|
|
NCV
5507
Virtus Convertible & Income Fund
NCV
$390M
| $247K | ﹤0.01% |
18,922
+7,208
| +62% | +$92.4K |
|
5508
Global Industrial
GIC
$1.49B
| $246K | ﹤0.01% |
7,848
-9,716
| -55% | -$356K |
|
5509
Invesco DB Base Metals Fund
DBB
$315M
| $246K | ﹤0.01% |
12,208
+3,731
| +44% | +$75.4K |
|
5510
Clearwater Paper
CLW
$376M
| $246K | ﹤0.01% |
5,070
-7,485
| -60% | -$352K |
|
|
GMEX
5511
GMEX Robotics
GMEX
$1.12M
| $246K | ﹤0.01% |
1
| – | – |
|
5512
Arq
ARQ
$89.3M
| $246K | ﹤0.01% |
40,447
+39,667
| +5,086% | +$274K |
|
5513
John Marshall Bancorp
JMSB
$329M
| $245K | ﹤0.01% |
14,055
-7,155
| -34% | -$122K |
|
5514
Medifast
MED
$141M
| $245K | ﹤0.01% |
11,221
-112,580
| -91% | -$3M |
|
5515
eHealth
EHTH
$43.9M
| $243K | ﹤0.01% |
53,748
+23,970
| +80% | +$121K |
|
5516
Acco Brands
ACCO
$407M
| $243K | ﹤0.01% |
51,800
-65,124
| -56% | -$325K |
|
5517
Orion Group Holdings
ORN
$418M
| $243K | ﹤0.01% |
25,555
+6,854
| +37% | +$60.6K |
|
5518
FT Vest US Equity Buffer ETF September
FSEP
$1.23B
| $243K | ﹤0.01% |
5,552
+4,989
| +886% | +$213K |
|
5519
FT Vest US Equity Buffer ETF December
FDEC
$1.35B
| $243K | ﹤0.01% |
5,706
+1,885
| +49% | +$78.2K |
|
5520
FT Energy Income Partners Strategy ETF
EIPX
$556M
| $243K | ﹤0.01% |
10,387
+4,516
| +77% | +$106K |
|
|
TPHE
5521
DELISTED
Timothy Plan High Dividend Stock Enhanced ETF
TPHE
| $242K | ﹤0.01% |
10,135
+7,229
| +249% | +$174K |
|
5522
First Trust Eurozone AlphaDEX
FEUZ
$138M
| $242K | ﹤0.01% |
5,822
+5,769
| +10,885% | +$248K |
|
|
TDF
5523
Templeton Dragon Fund
TDF
$280M
| $241K | ﹤0.01% |
29,993
-773
| -3% | -$6.34K |
|
5524
Principal Exchange-Traded Funds Principal US Small-Cap ETF
PSC
$2.3B
| $240K | ﹤0.01% |
4,977
+3,610
| +264% | +$173K |
|
|
TIGR
5525
UP Fintech Holding
TIGR
$861M
| $239K | ﹤0.01% |
56,934
+56,899
| +162,569% | +$224K |
|
Similar funds
UBS Group's Q2 2024 Portfolio in Review
As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
UBS Group's Q2 2024 filing shows 1,231 new, 3,688 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
- UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
- UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
- UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
- UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
- UBS Group opened 1,231 new positions and closed 1,043 in Q2 2024.
- UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.
Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.